Endurant Capital Management’s Gilead Sciences GILD Stock Holding History

Endurant Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-155,793	Closed	-$10.1M	–	62
2019 Q1	$10.1M	Buy	+155,793	New	+$10.4M	4%	7
2018 Q4	–	Sell	-10,315	Closed	-$796K	–	62
2018 Q3	$796K	Sell	10,315 -72,548	-88%	-$5.48M	0.35%	52
2018 Q2	$5.87M	Buy	82,863 +35,663	+76%	+$2.52M	2.55%	14
2018 Q1	$3.56M	Buy	+47,200	New	+$3.75M	1.33%	25
2017 Q4	–	Sell	-27,357	Closed	-$2.22M	–	81
2017 Q3	$2.22M	Sell	27,357 -72,543	-73%	-$5.55M	0.67%	53
2017 Q2	$7.07M	Buy	99,900 +77,900	+354%	+$5.18M	2%	22
2017 Q1	$1.49M	Buy	+22,000	New	+$1.55M	0.48%	55
2016 Q4	–	Sell	-20,810	Closed	-$1.65M	–	80
2016 Q3	$1.65M	Sell	20,810 -7,000	-25%	-$569K	0.61%	38
2016 Q2	$2.32M	Sell	27,810 -40,000	-59%	-$3.55M	0.78%	36
2016 Q1	$6.23M	Buy	67,810 +25,400	+60%	+$2.29M	2.02%	22
2015 Q4	$4.29M	Buy	42,410 +11,410	+37%	+$1.19M	1.43%	26
2015 Q3	$3.04M	Sell	31,000 -23,800	-43%	-$2.64M	1.02%	37
2015 Q2	$6.42M	Buy	54,800 +21,700	+66%	+$2.37M	1.89%	15
2015 Q1	$3.25M	Buy	33,100 +26,500	+402%	+$2.69M	1.07%	35
2014 Q4	$622K	Buy	+6,600	New	+$683K	0.24%	76

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Endurant Capital Management's GILD Position: Q2 2019 in Review

Endurant Capital Management sold out of Gilead Sciences (GILD) in Q2 2019, closing a stake of 155,793 shares — an estimated $10.1M sold.

Endurant Capital Management first reported a position in GILD in Q4 2014 and held it in 15 quarters. The position peaked at $10.1M in Q1 2019. 1,483 funds tracked by Wall St. Rank hold GILD as of Q2 2019.

Endurant Capital Management reported no remaining Gilead Sciences position as of Q2 2019 after selling out during the quarter.
Endurant Capital Management sold 155,793 Gilead Sciences shares in Q2 2019, an estimated $10.1M.
Endurant Capital Management first reported a position in Gilead Sciences in Q4 2014 and held it in 15 quarters.
Endurant Capital Management's Gilead Sciences position peaked at $10.1M in Q1 2019.
1,483 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2019.

Based on Endurant Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.